Literature DB >> 24170549

Conjunctival melanomas harbor BRAF and NRAS mutations--response.

Klaus G Griewank1, Henrike Westekemper, Bastian Schilling, Elisabeth Livingstone, Tobias Schimming, Antje Sucker, Uwe Hillen, Klaus-Peter Steuhl, Lisa Zimmer, Dirk Schadendorf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24170549     DOI： 10.1158/1078-0432.CCR-13-2368

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  6 in total

Review 1.  Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies.

Authors:  Anastasia Gkiala; Sotiria Palioura
Journal:  Clin Ophthalmol       Date:  2020-10-09

Review 2.  Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma.

Authors:  Ernesto Rossi; Giovanni Schinzari; Brigida Anna Maiorano; Monica Maria Pagliara; Alessandro Di Stefani; Emilio Bria; Ketty Peris; Maria Antonietta Blasi; Giampaolo Tortora
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

Review 3.  Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know.

Authors:  Kalijn Fredrike Bol; Marco Donia; Steffen Heegaard; Jens Folke Kiilgaard; Inge Marie Svane
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

Review 4.  New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells.

Authors:  Jennifer Peil; Felix Bock; Friedemann Kiefer; Rebecca Schmidt; Ludwig M Heindl; Claus Cursiefen; Simona L Schlereth
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

5.  A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib.

Authors:  A Maleka; G Åström; P Byström; G J Ullenhag
Journal:  BMC Cancer       Date:  2016-08-12       Impact factor: 4.430

6.  NF1 mutations in conjunctival melanoma.

Authors:  S L Scholz; I Cosgarea; D Süßkind; R Murali; I Möller; H Reis; S Leonardelli; B Schilling; T Schimming; E Hadaschik; C Franklin; A Paschen; A Sucker; K P Steuhl; D Schadendorf; H Westekemper; K G Griewank
Journal:  Br J Cancer       Date:  2018-03-21       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.